Efficacy and safety comparison between liraglutide as add-on therapy to insulin and insulin dose-increase in Chinese subjects with poorly controlled type 2 diabetes and abdominal obesity

Схожие документы

• Preserved pharmacokinetics and pharmacodynamics of insulin degludec and liraglutide when administered as insulin degludec/liraglutide in a Chinese population
  по: Hongzhong Liu, et al.
  Опубликовано: (2022-04-01)
• Changes in liraglutide-induced body composition are related to modifications in plasma cardiac natriuretic peptides levels in obese type 2 diabetic patients
  по: Li, Chun-Jun, et al.
  Опубликовано: (2014)
• Efficacy and safety of vildagliptin, Saxagliptin or Sitagliptin as add-on therapy in Chinese patients with type 2 diabetes inadequately controlled with dual combination of traditional oral hypoglycemic agents
  по: Li, Chun-Jun, et al.
  Опубликовано: (2014)
• Single-dose pharmacokinetics of levetiracetam in healthy Chinese male subjects
  по: Zhao, Qian, et al.
  Опубликовано: (2007)
• Zinc-α(2)-Glycoprotein Is Associated With Insulin Resistance in Humans and Is Regulated by Hyperglycemia, Hyperinsulinemia, or Liraglutide Administration: Cross-sectional and interventional studies in normal subjects, insulin-resistant subjects, and subjects with newly diagnosed diabetes
  по: Yang, Mengliu, et al.
  Опубликовано: (2013)